Logo image of MRS.CA

MISSION READY SOLUTIONS INC (MRS.CA) Stock Fundamental Analysis

TSX-V:MRS - TSX Venture Exchange - CA60511F1027 - Common Stock - Currency: CAD

0.035  -0.01 (-22.22%)

Fundamental Rating

1

MRS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 12 industry peers in the Aerospace & Defense industry. MRS has a bad profitability rating. Also its financial health evaluation is rather negative. MRS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MRS has reported negative net income.
In the past year MRS has reported a negative cash flow from operations.
MRS had negative earnings in each of the past 5 years.
MRS had negative operating cash flow in 4 of the past 5 years.
MRS.CA Yearly Net Income VS EBIT VS OCF VS FCFMRS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -5M -10M -15M -20M

1.2 Ratios

MRS has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRS.CA Yearly ROA, ROE, ROICMRS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K

1.3 Margins

MRS has a Gross Margin (19.61%) which is comparable to the rest of the industry.
MRS's Gross Margin has improved in the last couple of years.
MRS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.8%
GM growth 5YN/A
MRS.CA Yearly Profit, Operating, Gross MarginsMRS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

MRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MRS has more shares outstanding
The debt/assets ratio for MRS is higher compared to a year ago.
MRS.CA Yearly Shares OutstandingMRS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
MRS.CA Yearly Total Debt VS Total AssetsMRS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -41.15, we must say that MRS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MRS (-41.15) is worse than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -41.15
ROIC/WACCN/A
WACC7.41%
MRS.CA Yearly LT Debt VS Equity VS FCFMRS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.11 indicates that MRS may have some problems paying its short term obligations.
MRS has a Current ratio of 0.11. This is amonst the worse of the industry: MRS underperforms 86.67% of its industry peers.
A Quick Ratio of 0.08 indicates that MRS may have some problems paying its short term obligations.
MRS's Quick ratio of 0.08 is on the low side compared to the rest of the industry. MRS is outperformed by 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.08
MRS.CA Yearly Current Assets VS Current LiabilitesMRS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

MRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -229.45%.
The Revenue for MRS has decreased by -79.37% in the past year. This is quite bad
MRS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.68% yearly.
EPS 1Y (TTM)-229.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-376.81%
Revenue 1Y (TTM)-79.37%
Revenue growth 3Y-36.13%
Revenue growth 5Y9.68%
Sales Q2Q%-8.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.94%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRS.CA Yearly Revenue VS EstimatesMRS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
MRS.CA Yearly EPS VS EstimatesMRS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 0.01 0.01 0.02 0.02

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MRS. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 1.70, which indicates a rather cheap valuation of MRS.
100.00% of the companies in the same industry are more expensive than MRS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.11, MRS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.7
MRS.CA Price Earnings VS Forward Price EarningsMRS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRS.CA Per share dataMRS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

MRS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MISSION READY SOLUTIONS INC

TSX-V:MRS (7/4/2023, 7:00:00 PM)

0.035

-0.01 (-22.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.54M
Analysts84.44
Price Target0.41 (1071.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.7
P/S 1.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0.02
Fwd EY58.86%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS-0.04
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.61%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.8%
GM growth 5YN/A
F-Score3
Asset Turnover2.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.08
Altman-Z -41.15
F-Score3
WACC7.41%
ROIC/WACCN/A
Cap/Depr(3y)2.67%
Cap/Depr(5y)4.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-229.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-376.81%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-79.37%
Revenue growth 3Y-36.13%
Revenue growth 5Y9.68%
Sales Q2Q%-8.46%
Revenue Next Year29.94%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year274.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-138.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-138.16%
OCF growth 3YN/A
OCF growth 5YN/A